SG10201505844WA - Orally disintegrating tablet containing acarbose - Google Patents

Orally disintegrating tablet containing acarbose

Info

Publication number
SG10201505844WA
SG10201505844WA SG10201505844WA SG10201505844WA SG10201505844WA SG 10201505844W A SG10201505844W A SG 10201505844WA SG 10201505844W A SG10201505844W A SG 10201505844WA SG 10201505844W A SG10201505844W A SG 10201505844WA SG 10201505844W A SG10201505844W A SG 10201505844WA
Authority
SG
Singapore
Prior art keywords
orally disintegrating
tablet containing
disintegrating tablet
containing acarbose
acarbose
Prior art date
Application number
SG10201505844WA
Inventor
Axel Schneeweis
Tobias Laich
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of SG10201505844WA publication Critical patent/SG10201505844WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG10201505844WA 2010-04-27 2011-04-26 Orally disintegrating tablet containing acarbose SG10201505844WA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10161114 2010-04-27

Publications (1)

Publication Number Publication Date
SG10201505844WA true SG10201505844WA (en) 2015-09-29

Family

ID=44344015

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2012076147A SG184851A1 (en) 2010-04-27 2011-04-26 Orally disintegrating tablet containing acarbose
SG10201505844WA SG10201505844WA (en) 2010-04-27 2011-04-26 Orally disintegrating tablet containing acarbose

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2012076147A SG184851A1 (en) 2010-04-27 2011-04-26 Orally disintegrating tablet containing acarbose

Country Status (26)

Country Link
US (1) US20130131003A1 (en)
EP (1) EP2563329B1 (en)
JP (1) JP5944378B2 (en)
KR (1) KR101788350B1 (en)
CN (2) CN102905687A (en)
AU (1) AU2011247642C1 (en)
BR (1) BR112012027303A2 (en)
CA (1) CA2797365A1 (en)
CL (1) CL2012003011A1 (en)
CO (1) CO6640213A2 (en)
CR (1) CR20120548A (en)
CU (1) CU20120152A7 (en)
DO (1) DOP2012000277A (en)
EC (1) ECSP12012279A (en)
ES (1) ES2623025T3 (en)
GT (1) GT201200290A (en)
IL (1) IL222368B (en)
MX (1) MX348865B (en)
MY (1) MY179724A (en)
NZ (1) NZ603199A (en)
PE (1) PE20130403A1 (en)
SG (2) SG184851A1 (en)
SI (1) SI2563329T1 (en)
TW (1) TWI556823B (en)
UA (1) UA111155C2 (en)
WO (1) WO2011134962A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201100150A2 (en) * 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Water soluble dosage forms
WO2013115741A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic Pharmaceutical compositions comprising alpha-glucosidase inhibitor
WO2013115738A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic Micronized acarbose
CA2922849A1 (en) 2012-08-31 2014-03-06 Ixchel Pharma, Llc Agents useful for treating obesity, diabetes and related disorders
CN104013590A (en) * 2014-05-09 2014-09-03 万特制药(海南)有限公司 Acarbose-containing medicinal composition and preparation method thereof
EP3233066B1 (en) 2014-12-17 2021-11-10 Empros Pharma AB A modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders
CN105213341A (en) * 2015-10-29 2016-01-06 无锡福祈制药有限公司 A kind of acarbose tablet and preparation method thereof
CN113081984B (en) * 2021-04-19 2023-06-02 北京阳光诺和药物研究股份有限公司 Acarbose orally disintegrating tablet and preparation method thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134591A1 (en) * 1981-09-01 1983-03-10 Bayer Ag, 5090 Leverkusen NEW MEDICINE PREPARATIONS FOR GLYCOSIDE HYDROLASE INHIBITORS
JPH10182687A (en) * 1996-10-21 1998-07-07 Bayer Yakuhin Kk Stabilization of storage of acarbose
DE19802700A1 (en) * 1998-01-24 1999-07-29 Bayer Ag Preparation of fast-dissolving tablets for controlling blood sugar levels
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
KR100682836B1 (en) * 2004-12-06 2007-02-15 엘지전자 주식회사 Organic electroluminescent device
US20060229261A1 (en) * 2005-04-12 2006-10-12 John Devane Acarbose methods and formulations for treating chronic constipation
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
WO2007099908A1 (en) * 2006-02-27 2007-09-07 Matsushita Electric Industrial Co., Ltd. Wearable terminal, mobile imaging sound collecting device, and device, method, and program for implementing them
FI20070521L (en) * 2006-11-10 2008-05-11 Atacama Labs Oy Grains, tablets and granulation process
CN101411715B (en) * 2007-10-19 2012-03-28 杭州华东医药集团生物工程研究所有限公司 Pharmaceutical composition containing acarbose
JP5291324B2 (en) * 2007-11-01 2013-09-18 沢井製薬株式会社 Orally disintegrating tablets
JP2009114113A (en) * 2007-11-06 2009-05-28 Nipro Corp Intraorally disintegrable tablet and method for producing the same
RU2010128019A (en) * 2007-12-08 2012-01-20 Байер Шеринг Фарма Акциенгезельшафт (DE) ORAL DISPERSABLE TABLET
AR069875A1 (en) * 2007-12-21 2010-02-24 Eurand Inc TEMAZEPAM COMPOSITIONS FOR ORAL DISINTEGRATION TABLETS AND PREPARATION METHOD
CN102088959B (en) * 2008-06-20 2016-05-25 默克专利股份有限公司 Tablet matrix that can directly compress and quickly disintegrated

Also Published As

Publication number Publication date
JP5944378B2 (en) 2016-07-05
CN102905687A (en) 2013-01-30
NZ603199A (en) 2014-05-30
CA2797365A1 (en) 2011-11-03
ECSP12012279A (en) 2012-11-30
AU2011247642A1 (en) 2012-11-08
US20130131003A1 (en) 2013-05-23
EP2563329B1 (en) 2017-04-12
MY179724A (en) 2020-11-11
KR20130062926A (en) 2013-06-13
CO6640213A2 (en) 2013-03-22
MX348865B (en) 2017-07-03
IL222368B (en) 2018-11-29
IL222368A0 (en) 2012-12-31
WO2011134962A3 (en) 2012-05-03
CN106924199A (en) 2017-07-07
GT201200290A (en) 2014-09-24
UA111155C2 (en) 2016-04-11
MX2012012459A (en) 2012-11-21
EP2563329A2 (en) 2013-03-06
ES2623025T3 (en) 2017-07-10
CL2012003011A1 (en) 2013-04-19
PE20130403A1 (en) 2013-04-13
WO2011134962A2 (en) 2011-11-03
SI2563329T1 (en) 2017-05-31
TWI556823B (en) 2016-11-11
AU2011247642B2 (en) 2015-05-14
SG184851A1 (en) 2012-11-29
CR20120548A (en) 2013-03-11
BR112012027303A2 (en) 2017-10-24
JP2013525404A (en) 2013-06-20
TW201141490A (en) 2011-12-01
AU2011247642C1 (en) 2015-11-12
DOP2012000277A (en) 2012-12-15
KR101788350B1 (en) 2017-10-19
CU20120152A7 (en) 2014-02-28

Similar Documents

Publication Publication Date Title
ZA201304617B (en) Orally disintegrating tablet
ZA201304366B (en) Orally disintegrating tablet
EP2415466A4 (en) Orally disintegrating coated tablet
EP2572995A4 (en) Tablet cassette
PL2368704T3 (en) Tablet outlet
ZA201305567B (en) Orally dispersible tablet
IL222368A0 (en) Orally disintegrating tablet containing acarbose
EP2510950A4 (en) Dry-coated orally disintegrating tablet
AU330102S (en) Tablet dispenser
EP2810659A4 (en) Orally disintegrating tablet containing bitterness-masking granules
ZA201200761B (en) Tablet
EP2409688A4 (en) Orally disintegrating tablet
IL222754A0 (en) Enteric tablet
AU330360S (en) Tablet
EP2612657A4 (en) Orally disintegrating tablet
HK1204968A1 (en) Rapidly disintegrating coated tablets
IL222753A0 (en) Enteric tablet
GB0920041D0 (en) Tablet
ZA201201059B (en) Tablet manufacture
AU335048S (en) Tablet
GB2479754B (en) Can crusher
AU331949S (en) Tablet
AU330359S (en) Tablet
AU338806S (en) Tablet
GB201112758D0 (en) Tablet